Abstract
Full-length human (hFMO2.1) and monkey (mFMO2) flavin-containing monooxygenase proteins, which share 97% sequence identity, were produced by baculovirus-mediated expression in insect cells and assayed for S-oxygenation under conditions known to affect FMO activity. Both enzymes demonstrated maximal activity at pH 9.5; but hFMO2.1 retained significantly more activity than mFMO2 did at pH 9.0 and higher. hFMO2.1 also retained significantly more activity than mFMO2 did in the presence of magnesium and all detergents tested. Although hFMO2.1 had more residual activity after heating at 45°C than mFMO2, under some conditions, both had less than 10% of control activity, whereas expressed rabbit FMO2 retained over 50% activity. Screening for NADPH-oxygenation by hFMO2.1, indicated that substituted thioureas with a small cross-sectional area (2.4–4.3 Å) are good substrates, whereas 1,3-diphenylthiourea (11.2 Å) was not oxygenated. We confirmed the presence of hFMO2.1 in lung tissue from a heterozygous individual (hFMO2*1/hFMO2*2A) by Western analysis and confirmed activity by S-oxygenation. These microsomes also demonstrated a heat-associated loss of activity similar to expressed hFMO2.1. The heat sensitivity of hFMO2.1 may partially explain why activity in post mortem human lung samples has previously been unreported. Individuals that have the FMO2*1allele-encoding full-length hFMO2.1 may exhibit altered drug metabolism in the lung.
Footnotes
-
↵1 Current Address: Department of Pharmacology, University of California San Diego, La Jolla, CA.
-
↵2 Department of Statistics, Oregon State University, Corvallis, OR.
-
This work was supported by Public Health Service Grant HL38650. Part of this study was presented at the 40th Annual Meeting of the Society of Toxicology, San Francisco, CA, March 2001, an abstract of which appeared in The Toxicologist60:158.
- Abbreviations used are::
- FMO
- flavin-containing monooxygenase
- AA
- amino acid
- CHAPS
- 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid
- DTNB
- 5,5-dithiobis-(2-nitrobenzoate)
- PMSF
- phenylmethylsulfonyl fluoride
- Sf9
- Spodoptera frugiperda
- high/storage
- high protein concentration in storage buffer
- low/tricine
- low protein concentration in tricine buffer
- Received May 23, 2001.
- Accepted August 24, 2001.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|